Not sure on the technical front but I do know in comparison to RAP we are currently peanuts at a 5 mill MC. With a product that has potential multiple income streams I do see strong growth potential. The key will be how much more dilution will be needed to get Epat to commercialisation.
- Forums
- ASX - By Stock
- MNQ
- MNQ Chart Thread
MNQ Chart Thread, page-14
Featured News
Add MNQ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online